Growth Metrics

Goldenwell Biotech (GWLL) Shares Outstanding (2019 - 2025)

Goldenwell Biotech's Shares Outstanding history spans 7 years, with the latest figure at $99.0 million for Q3 2025.

  • For Q3 2025, Shares Outstanding rose 900.0% year-over-year to $99.0 million; the TTM value through Sep 2025 reached $99.0 million, up 900.0%, while the annual FY2024 figure was $99.0 million, 900.0% up from the prior year.
  • Shares Outstanding reached $99.0 million in Q3 2025 per GWLL's latest filing, up from $9.9 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $99.0 million in Q4 2022 to a low of $9.9 million in Q4 2023.
  • Average Shares Outstanding over 5 years is $69.5 million, with a median of $96.0 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding: crashed 90.0% in 2023, then soared 900.0% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $91.5 million in 2021, then grew by 8.2% to $99.0 million in 2022, then plummeted by 90.0% to $9.9 million in 2023, then skyrocketed by 900.0% to $99.0 million in 2024, then changed by 0.0% to $99.0 million in 2025.
  • Per Business Quant, the three most recent readings for GWLL's Shares Outstanding are $99.0 million (Q3 2025), $9.9 million (Q2 2025), and $9.9 million (Q1 2025).